BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23192781)

  • 1. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
    Davenport MS; Caoili EM; Kaza RK; Hussain HK
    Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
    Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
    Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
    Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL
    AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
    Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
    Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
    Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
    Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
    Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J
    Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    Allen BC; Ho LM; Jaffe TA; Miller CM; Mazurowski MA; Bashir MR
    AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
    Well L; Rausch VH; Adam G; Henes FO; Bannas P
    Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
    [No Abstract]   [Full Text] [Related]  

  • 12. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
    Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U
    Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging.
    Motosugi U; Bannas P; Bookwalter CA; Sano K; Reeder SB
    Radiology; 2016 Apr; 279(1):93-102. PubMed ID: 26473642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
    Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P
    Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
    Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR
    Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging.
    Hayashi T; Saitoh S; Tsuji Y; Takahashi J; Tagaya N; Hiramoto M; Fukuzawa K; Tano M; Miyati T; Kumada H
    Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
    McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
    Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
    Aran S; Shaqdan KW; Abujudeh HH
    Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.